KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Inventory Average: 2013-2024

Historic Inventory Average for Supernus Pharmaceuticals (SUPN) over the last 12 years, with Dec 2024 value amounting to $65.9 million.

  • Supernus Pharmaceuticals' Inventory Average fell 6.59% to $61.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 million, marking a year-over-year decrease of 6.59%. This contributed to the annual value of $65.9 million for FY2024, which is 22.05% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Inventory Average of $65.9 million as of FY2024, which was down 22.05% from $84.5 million recorded in FY2023.
  • Supernus Pharmaceuticals' Inventory Average's 5-year high stood at $88.8 million during FY2022, with a 5-year trough of $37.5 million in FY2020.
  • Moreover, its 3-year median value for Inventory Average was $84.5 million (2023), whereas its average is $79.7 million.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 79.16% in 2021, then decreased by 22.05% in 2024.
  • Over the past 5 years, Supernus Pharmaceuticals' Inventory Average (Yearly) stood at $37.5 million in 2020, then skyrocketed by 79.16% to $67.1 million in 2021, then soared by 32.18% to $88.8 million in 2022, then fell by 4.82% to $84.5 million in 2023, then fell by 22.05% to $65.9 million in 2024.